Nigel Langley
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Analytical Chemistry top 10%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Drug Solubulity and Delivery Systems 11
- Advanced Drug Delivery Systems 8
-
- Protein purification and stability 3
- Co-authors
- Karl Kolter (10 shared papers)Andreas Gryczke (7 shared papers)Soumyajit Majumdar (6 shared papers)Michael A. Repka (6 shared papers)Bader B. Alsulays (4 shared papers)Jiannan Lu (3 shared papers)Justin M. Keen (1 shared paper)Dave A. Miller (1 shared paper)
- Journals
- AAPS PharmSciTech (4 papers)Journal of Pharmacy and Pharmacology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)International Journal of Pharmaceutics (1 paper)Journal of Pharmaceutical Innovation (1 paper)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Nigel Langley
17 papers receiving 518 citations
Peers
Comparison fields: 5 of 78
- Pharmaceutical Science 355
- Analytical Chemistry 69
- Drug Discovery 1
- Pharmacology 40
- Spectroscopy 64
Countries citing papers authored by Nigel Langley
This map shows the geographic impact of Nigel Langley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Langley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Langley more than expected).
Fields of papers citing papers by Nigel Langley
This network shows the impact of papers produced by Nigel Langley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Langley. The network helps show where Nigel Langley may publish in the future.
Co-authors
The 25 scholars most cited alongside Nigel Langley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 87 | |
| 2 | 2013 | 80 | |
| 3 | 2016 | 62 | |
| 4 | 2015 | 58 | |
| 5 | 2018 | 47 | |
| 6 | 2015 | 47 | |
| 7 | 2013 | 30 | |
| 8 | 2014 | 26 | |
| 9 | 2019 | 21 | |
| 10 | 2015 | 18 | |
| 11 | 2022 | 18 | |
| 12 | 2016 | 17 | |
| 13 | 2021 | 12 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2011 | 1 |
About Nigel Langley
Nigel Langley is a scholar working on Pharmaceutical Science, Molecular Biology, Analytical Chemistry, Biomedical Engineering and Materials Chemistry, having authored 17 papers that have together received 531 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (11 papers), Advanced Drug Delivery Systems (8 papers), Analytical Methods in Pharmaceuticals (4 papers), Protein purification and stability (3 papers), Crystallization and Solubility Studies (3 papers), 3D Printing in Biomedical Research (2 papers), Advanced Chemical Sensor Technologies (1 paper) and Bee Products Chemical Analysis (1 paper). The work is most often cited by research in Pharmaceutical Science (355 citations), Analytical Chemistry (69 citations), Drug Discovery (1 citation), Pharmacology (40 citations) and Spectroscopy (64 citations). Nigel Langley has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Karl Kolter, Andreas Gryczke, Soumyajit Majumdar, Michael A. Repka, Michael A. Repka, Bader B. Alsulays, Jiannan Lu, Justin M. Keen, Dave A. Miller and James W. McGinity. Their work appears in journals such as AAPS PharmSciTech, Journal of Pharmacy and Pharmacology, European Journal of Pharmaceutical Sciences, International Journal of Pharmaceutics and Journal of Pharmaceutical Innovation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.